[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 22, Issue 6 (Bimonthly 2018) ::
Feyz 2018, 22(6): 595-601 Back to browse issues page
Investigation of exon 4 mutations of phenylalanine hydroxylase gene in phenylketonuria patients in Guilan Province using PCR-sequencing
Neda Pourvatan , Zeinab Khazaei -Koohpar *
Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Tonekabon Branch, Islamic Azad University, Tonekabon, I. R. Iran. , dz.khazaei@gmail.com
Abstract:   (393 Views)
Background: Phenylketonuria (PKU) is a heterogeneous and autosomal recessive metabolic disorder that is mainly caused by mutations in the hepatic phenylalanine hydroxylase (PAH) gene. Distribution pattern of mutations in the PAH gene are specific to each population. To date, no reports of phenylketonuria molecular analysis have been found in this population. The aim of this study was to identify PAH mutations within exon 4 in PKU patients in Guilan Province and compare it with the studies in other parts of Iran.
Materials and Methods: In this cross-sectional and descriptive study, 25 unrelated PKU patients (age range, 1-21 years) were identified from different regions of Guilan Province during a one-year period. After collecting blood samples and DNA extraction, the DNA fragments containing the exon 4 of the PAH gene and its flanking intronic sequences were amplified and sequenced.
Results: In this study, IVS4+5G>T mutation (10%) was identified. This mutation was found in two homozygous PKU patients and one heterozygous patient; they had mPKU and cPKU phenotypes, respectively and their parents were third degree relatives. In addition, IVS4+47C>T (28%) and IVS3-22C>T (8%) polymorphisms were also detected.
Conclusion: Investigation of mutations in the PAH gene can be a useful tool for molecular detection of the PKU disease and carrier detection in this population. Moreover, the other 12 remaining exons need to be analyzed to obtain the full spectrum of mutations of this gene among the PKU patients in Guilan Province.
Keywords: Guilan Province, PKU, PAH, mutation, exon4. .PCR-Sequencing.
Full-Text [PDF 653 kb]   (156 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2018/08/15 | Accepted: 2018/12/2 | Published: 2019/01/30
1. Hamzehloei T, Hosseini SA, Vakili R, Mojarad M. Mutation spectrum of the PAH gene in the PKU patients from Khorasan Razavi province of Iran. Gene 2012; 506(1): 230-2.
2. Koochmeshgi J, Bagheri A, Hosseini-Mazinani SM. Incidence of phenylketonuria in Iran estimated from consanguineous marriages. Inherit Metab Dis 2002; 25(1): 80-1.
3. Hosseini-Mazinani SM, Koochmeshgi J, Kha‌zaee- Koohpar Z, Hosein-Pur-Nobari N, Seifati SM, Carrier detection of phenylketonuria in Iranian families by variable number tandem-repeat poly‌mor‌phism analysis. East Mediterr Health J 2008; 14(6): 1445–51.
4. Zare-Karizi S, Hossini–Mazinani SM, Khazaei-ko‌o‌hpar Z, Seifati SM, Shahsavan-behboodi B, Akbari MT et al. Mutation spectrum of phenyl‌keto‌nuria in Iranian population. Mol Genet Metab 2011; 102(1): 29-32.
5. Fazeli Z, Vallian S. Phenylketonuria from gen‌et‌ics to clinics: An Iranian prospect. Iran J Biotech 2011; 9(3): 163-72.
6. Moradi K, Alibakhshi R, Ghadiri K, Khatami SR, Galehdari H. Molecular analysis of exons 6 and 7 of phenylalanine hydroxylase gene mutations in Phenylketonuria patients in Western Iran. Indian J Hum Genet 2012; 18(3): 290.
7. Alibakhshi R, Moradi K, Biglari M, Shafieenia S. Spectrum of phenylalanine hydroxylase gene mutations in Hamadan and Lorestan provinces of iran and their associations with variable number of tandem repeat alleles. Iran J Med Sci 2018; 43(3): 318-23.
8. Aulehla-Scholz C, Heilbronner H. Mutational spectrum in german patients with phenylalanine hydroxylase deficiency. Hum Mutation Mutation Brief 2003; 21(4): 1-6.
9. Razipour M , Alavinejad E, Sajedi SZ, Talebi S, Entezam M, Mohajer N, et al. Genetic study of the PAH locus in the Iranian population: familial gene mutations and minihaplotypes. Metabolic Brain Dis 2017; 32(5): 1685–91.
10. Shirzad T, Saeidian AH, Bagherian H, Saleh‌pour S, Setoodeh A, Alaei M, et al. Molecular gene‌t‌ics of a cohort of 635 cases of phenylketonuria in a consanguineous population. J Inherit Metab Dis 2018; 1-9.
11. Binaafar S, Mahdieh N. Genetics of Phenyl‌ketonuria in Iran: A Review Study. J Mazandaran Univ Med Sci 2017; 27(147): 446-55. [in Persian]
12. Haerian Ardakani H, Khazaei Koohpar Z, Moha‌mmadian S. Mutations Analysis of exon 10 - 11 of phenylalanine Hydroxylase gene in phenyl‌ketonuria patients from Golestan province. Razi J Med Sci 2018; 25(172): 38-46.
13. Alibakhshi R., Moradi K , Mohebbi Z, Ghadiri K. Mutation analysis of PAH gene in patients with PKU in western Iran and its association with poly‌morphisms: identification of four novel mutations. Metab Brain Dis 2014; 29(1): 131-8.
14. Biglari A, Saffari F, Rashvand Z, Alizadeh S, Najafipour R, Sahmani M, et al. Mutations of the pheny‌lalanine hydroxylase gene in Iranian patients with phenylketonuria. Springerplus 2015; 4(1): 542.
15. Alavinejad E, Sajedi SZ, Razipour M, Entezam M, Mohajer N, Setoodeh A et al. A novel variant in the PAH gene causing phenylketonuria in an iranian pedigree. Avicenna J Med Biotechnol 2017; 9(3): 146-9.
16. Bonyadi M, Omrani O, Mohamadi Mogha‌nj‌oghi S, Shiva S. Mutations of the phenylalanine hydroxylase gene in Iranian Azeri Turkish patients with phenylketonuria. Genet Test Mol Biomarkers 2010; 14(2): 233-5.
17. Daniele A, Cardillo G, Pennino C, Carbone MT, Scognamiglio D, Correra A, et al. Molecular epidemiology of phenylalanine hydroxylase deficie‌n‌cy in southern Italy: a 96% detection rate with ten novel mutations. Ann Hum Genet 2006; 71(2): 185–93.
18. Dobrowolski SF, Ellingson C, Coyne T, Grey J, Martin R, Naylor EW, et al. Mutations in the phenylalanine hydroxylasegene identified in 95 patients with phenylketonuria using novel systems of mutation scanning and specific genotyping based upon thermal melt profiles. Mol Genet Metab 2007; 91: 218–27.
19. Bercovich D, Elimelech A, Zlotogora J, Korem S, Yardeni T, Gal N, et al. Genotype–phenotype cor‌relations analysis of mutations in the phenyl‌ala‌nine hydroxylase (PAH) gene. J Hum Genet 2008; 53(5): 407–18.
20. De Lucca M, Arias I, Casique L, Araujo K, Merzon RM. Improving phenylketonuria geno‌ty‌p‌ing by screening for the IVS4+5g>t mutation in the PAH gene. Clin Chim Acta 2009; 402(1-2): 206–8.
21. Dobrowolski SF, Heintz C, Miller T, Ellingson C, Ellingson C, Özer I, et al. Molecular genetics and impact of residualin vitrophenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population. Mol Genet Metab 2011; 10: 116-21.
22. Baturina OA, Morozov IV. Comparative ana‌lysis of phenylalanine hydroxylase mutations spe‌c‌t‌‌rum in Novosibirsk and Kemerovo regions of Western Siberia, Russia. Eur J Med 2016; 11(1): 4-11.
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Pourvatan N, Khazaei -Koohpar Z. Investigation of exon 4 mutations of phenylalanine hydroxylase gene in phenylketonuria patients in Guilan Province using PCR-sequencing. Feyz. 2018; 22 (6) :595-601
URL: http://feyz.kaums.ac.ir/article-1-3666-en.html

Volume 22, Issue 6 (Bimonthly 2018) Back to browse issues page
مجله علمی پژوهشی فیض ::: دانشگاه علوم پزشکی کاشان KAUMS Journal ( FEYZ )
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 3937